Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-058220
Filing Date
2013-12-20
Accepted
2013-12-20 16:47:32
Documents
1
Period of Report
2013-12-19

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c648012_4x0.html 4  
1 MAIN DOCUMENT DESCRIPTION c648012_4x0.xml 4 3873
  Complete submission text file 0001209191-13-058220.txt   5456
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Issuer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address C/O INVIVO THERAPEUTICS HOLDINGS CORP. ONE KENDALL SQUARE, SUITE B14402 CAMBRIDGE MA 02139
Business Address
HESS BRIAN (Reporting) CIK: 0001559300 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-52089 | Film No.: 131292089